Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
763.98 | -48,33% | -27,12% | 687.891,71 | 0,69% | 2,63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
910.00 | -1,79% | 18,59% | 4.053.901,21 | 1,03% | 18,5% |
|
NYSE:JNJ
Johnson & Johnson
|
151.38 | 0% | 0% | 364.323,09 | 3,28% | 2,71% |
|
NYSE:MRK
Merck
|
128.66 | -8,25% | 5,21% | 325.870,86 | 2,38% | -19,03% |
|
NYSE:ABBV
AbbVie
|
161.59 | -20,76% | -10,29% | 285.346,57 | 3,84% | 7,03% |
|
SWX:NOVN
Novartis
|
93.49 | 8,01% | 21,37% | 190.757,59 | 3,55% | 4,67% |
|
NYSE:ABT
Abbott Laboratories
|
104.01 | 2,51% | 15,26% | 180.939,31 | 2,1% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
311.41 | -11,96% | -3,14% | 167.051,13 | 2,92% | 5,31% |
|
NYSE:MDT
Medtronic
|
84.30 | 26,54% | 39,64% | 111.935,44 | 3,3% | 2,09% |
|
LSE:GSK
GSK
|
18.10 | 5,36% | 20,88% | 73.812,48 | 3,2% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.71 | 59,28% | 69,46% | 90.631,65 | 5,33% | 13,54% |
|
ASX:CSL
CSL
|
279.58 | 22,78% | 43,75% | 135.107,8 | 1,28% | 7,18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.65 | 21,02% | 30,29% | 84.281,97 | 4,56% | 0,15% |
|
XTRA:MRK
Merck KGaA
|
158.30 | 8,74% | 24,31% | 68.825,34 | 1,42% | 10,29% |
|
NYSE:BDX
Becton Dickinson and Co
|
235.00 | 16,09% | 30,31% | 67.916,52 | 1,6% | 2,09% |
|
TSE:4568
Daiichi Sankyo Company
|
5415.00 | 0% | 0% | 10.380.257,66 | 1,11% | 0% |
|
NYSE:MMM
3M
|
100.08 | 66,19% | 81,89% | 55.380,39 | 6,06% | -2,45% |
|
TSE:4519
Chugai Pharmaceutical
|
4798.00 | 0% | 0% | 7.894.216,36 | 1,65% | 0% |
|
NasdaqGS:MRNA
Moderna
|
128.32 | -.111,1% | -.107,66% | 49.177,32 | 0% | 0% |
|
XTRA:BAS
BASF
|
49.36 | 15,56% | 41,79% | 44.054,89 | 6,93% | -13,88% |
